Brazil has provisionally authorized commercialization of the first biotech crop outside the usual cotton, corn and soybean varieties. The national technical commission for biosafety (CTNBio) on Sept. 15 approved transgenic golden mosaic virus-resistant beans jointly developed by BASF and the Brazilian agricultural research corporation (Embrapa). The disease is the most damaging to beans in South America and is present in all Brazilian regions. Full approval requires the assent of the Ministry of Agriculture. Embrapa researcher Francisco Aragão expects the product to be sold and ready for planting within three years.